Increase in CIP2A expression is associated with doxorubicin resistance-Reference-Cited by-同舟云学术

Increase in CIP2A expression is associated with doxorubicin resistance

Published:2011-01-15 Issue:5 Volume:585 Page:755-760
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:

Author:

Choi Yeon A.,Park Jeong Su,Park Mi Young,Oh Ki Sook,Lee Myung Sok,Lim Jong-Seok,Kim Keun Il,Kim Kun-yong,Kwon Junhye,Yoon Do Young,Moon Eun-Yi,Yang Young

Funder

National Research Foundation of Korea (NRF)

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.febslet.2011.01.018/fullpdf

Reference27 articles.

1. CIP2A is associated with human breast cancer aggressivity;Come;Clin. Cancer Res.,2009

2. CIP2A inhibits PP2A in human malignancies;Junttila;Cell,2007

3. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer;Khanna;J. Natl. Cancer Inst.,2009

4. CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells;Li;Clin. Cancer Res.,2008

5. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo;Pulverer;Oncogene,1994

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CIP2A induces PKM2 tetramer formation and oxidative phosphorylation in non-small cell lung cancer;Cell Discovery;2024-02-06

2. Exploring the composition of protein-ligand binding sites for cancerous inhibitor of PP2A (CIP2A) by inhibitor guided binding analysis: paving a new way for the Discovery of drug candidates against triple negative breast cancer (TNBC);Journal of Receptors and Signal Transduction;2024-01-02

3. Emerging roles of the CIP2A–TopBP1 complex in genome integrity;NAR Cancer;2023-10-11

4. A study conducted in breast cancer cells found that (valproic acid) inhibits CIP2A/C-MYC/PI3K/Akt/mTOR signaling molecules and PD-L1;2023-06-29

5. Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A;Nature Communications;2023-02-28